Adding tucatinib to standard first-line maintenance therapy in patients with HER2-positive metastatic breast cancer led to a clinically meaningful delay in disease progression, regardless of the ...

In the spring of last year, then-President Joe Biden tried to convince skeptical voters that the struggling economy was healthy. Then-candidate Donald Trump seized on the moment and vowed to lower ...